Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00557388 |
Recruitment Status :
Completed
First Posted : November 14, 2007
Last Update Posted : September 14, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Aging is associated with the loss of lean muscle mass, termed sarcopenia. Food intake and in particular the ingestion of protein or amino acids has been shown to be a powerful stimulus to promote net muscle protein anabolism. However this anabolic response following a meal-like protein bolus seems to be blunted in the elderly as compared to young adults.
The first aim of this proposal is to investigate the post-prandial muscle protein synthesis rates in young and elderly men in response to a meal-like protein bolus after a period of rest or physical activity (study A). The rest trial (REST) will act as a proof-of-principle study to examine the blunted protein synthetic response in the elderly, and as a control trial in comparison with the exercise trial (EXC) to establish the surplus value of physical activity prior to protein intake on muscle protein synthesis.
The second aim of this proposal is to determine the surplus value of an increased quantity of the ingested protein bolus (study B). Large amounts of protein (40 and 60 g) will be compared to a meal-like amount of protein (20 g) as a means to maximize plasma amino acid availability and/or to stimulate muscle protein anabolism.
The third aim of this proposal is to study the differences in quality of the ingested protein bolus (study C). Instead of significantly increasing the quantity of the protein bolus, we will also apply a more practical approach to augment skeletal muscle protein synthesis rates; modifying the digestibility or amino acid composition of a meal-like protein bolus.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Sarcopenia | Dietary Supplement: Protein/Amino Acids Other: Physical exercise | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 120 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly |
Study Start Date : | December 2007 |
Actual Primary Completion Date : | November 2010 |
Actual Study Completion Date : | November 2010 |
Arm | Intervention/treatment |
---|---|
Experimental: 1
Young men 18-30 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine Other: Physical exercise The physical exercise protocol will consist of low intensity cycling and light resistance-type exercise; after 5 minutes of self-paced cycling, subjects will perform 6 sets of 10 repetitions on the horizontal leg press machine (Technogym BV, Rotterdam, The Netherlands) and 6 sets of 10 repetitions on the leg extension machine (Technogym BV, Rotterdam, The Netherlands). The first 2 sets of both resistance exercises will be performed at 40% of the subjects' 1RM. Sets 3-4, and 5-6 will be performed at 55% and 75% of 1RM, respectively, with 2 minutes rest intervals between sets. |
Experimental: 2
Young men 18-30 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine |
Experimental: 3
Old men 70-85 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine Other: Physical exercise The physical exercise protocol will consist of low intensity cycling and light resistance-type exercise; after 5 minutes of self-paced cycling, subjects will perform 6 sets of 10 repetitions on the horizontal leg press machine (Technogym BV, Rotterdam, The Netherlands) and 6 sets of 10 repetitions on the leg extension machine (Technogym BV, Rotterdam, The Netherlands). The first 2 sets of both resistance exercises will be performed at 40% of the subjects' 1RM. Sets 3-4, and 5-6 will be performed at 55% and 75% of 1RM, respectively, with 2 minutes rest intervals between sets. |
Experimental: 4
Old men 70-85 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine |
Experimental: 5
Old men 70-85 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine |
Experimental: 6
Old men 70-85 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine |
Experimental: 7
Old men 70-85 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine |
Experimental: 8
Old men 70-85 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine |
Experimental: 9
Old men 70-85 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine |
Experimental: 10
Old men 70-85 years, BMI < 27 kg/m2
|
Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine |
- All interventions will affect muscle protein synthesis. With the application of amino acid tracer methodology we are able to determine muscle protein synthesis. [ Time Frame: 6 hours ]
- Differences in rate of uptake/absorption from the intestine. [ Time Frame: 6 hours ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- In study A, non-obese male subjects (BMI <27) between the age of 18-30 yrs and 70-85 yrs will be selected.
- In studies B and C, non-obese male subjects (BMI <27) between the age of 70-85 yrs will be selected.
Exclusion Criteria:
- Type II diabetes or other known diseases
- Use of medication
- Female
- Other ages or BMI than indicated above
- Participation in any regular exercise program.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00557388
Netherlands | |
University of Maastricht | |
Maastricht, Limburg, Netherlands, 6200 MD |
Principal Investigator: | Luc van Loon, Phd | Maastricht University |
Responsible Party: | Maastricht University Medical Center |
ClinicalTrials.gov Identifier: | NCT00557388 |
Other Study ID Numbers: |
MEC 07-3-086 TIFN A-1002 |
First Posted: | November 14, 2007 Key Record Dates |
Last Update Posted: | September 14, 2011 |
Last Verified: | September 2011 |
muscle loss aging protein |
amino acids exercise protein synthesis |
Sarcopenia Muscular Atrophy Neuromuscular Manifestations Neurologic Manifestations |
Nervous System Diseases Atrophy Pathological Conditions, Anatomical |